ArticlebioRxiv : the preprint server for biology2026
CACNA1C as a Prognostic Biomarker and Therapeutic Target in High-Grade Serous Ovarian Cancer: Clinical Validation and Molecular Dynamics of Nifedipine Blockade.
Mohamed A Hammad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.